Finance

Beta
Lists
ATOS:BMV
Atossa Therapeutics Inc
MX$75.00
0.00%
(0.00) 1D
Jun 11, 10:37:32 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ATOS...
Mkt. cap
21.14M
Avg. vol.
89.00
Volume
0.00
52-wk high
MX$322.50
52-wk low
MX$75.00
No. of employees
16
Mkt. cap
21.14M
Avg. vol.
89.00
Volume
0.00
52-wk high
MX$322.50
52-wk low
MX$75.00
No. of employees
16
News stories
From sources across the web
About Atossa Therapeutics Inc
CEOSteven C. Quay
Employees16
Founded2008
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteatossatherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.50M
5.37M
6.16M
4.78M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.54M
3.88M
5.28M
5.09M
Operating expense
9.04M
9.25M
11.44M
9.87M
Total operating expenses
9.04M
9.25M
11.44M
9.87M
Operating income
-9.04M
-9.25M
-11.44M
-9.87M
Other non operating income
-28.00K
-11.00K
57.00K
-28.00K
EBT including unusual items
-8.42M
-8.69M
-10.94M
-9.59M
EBT excluding unusual items
-8.42M
-8.69M
-10.94M
-9.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-8.42M
-8.69M
-10.94M
-9.59M
Net profit margin
-
-
-
-
Earnings per share
-1.05
-1.05
-1.34
-1.11
Interest and investment income
645.00K
570.00K
442.00K
309.00K
Interest expense
-
-
-
-
Net interest expenses
645.00K
570.00K
442.00K
309.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.04M
-9.25M
-11.43M
-9.87M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer